Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Clemens Scheidegger
Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Immunoglobulin in Elderly Patients
Immunotherapy
Oncology
Allergy
Immunology
Related publications
Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in Patients With Primary Immunodeficiency Diseases: Interim Analysis of Adverse Events in a Global Post-Authorization Safety Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase 20
Drug Delivery
Medicine
Pharmaceutical Science
Presentation and Skin Biopsy Findings in Delayed Type Hypersensitivity Reactions to Facilitated Subcutaneous Immunoglobulin Replacement
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Arabinosylation of Recombinant Human Immunoglobulin-Based Protein Therapeutics
mAbs
Allergy
Immunology
Administration of Potassium by Subcutaneous Infusion in Elderly Patients.
BMJ
Improved Treatment Satisfaction With a New Human Subcutaneous Immunoglobulin (SCIG 20%) in Patients Previously Treated With IVIG
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Subcutaneous Administration of Rituximab (MabThera) and Trastuzumab (Herceptin) Using Hyaluronidase
British Journal of Cancer
Cancer Research
Oncology
Clinical Studies of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients With Malignant Lymphoma.
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Subcutaneous Immunoglobulin in Treating Inflammatory Neuromuscular Disorders
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
